Subscribe to our Newsletters !!

    Ovarian Cancer

    Researchers utilize funtional test to quantify the impact of inhertited varient in BRCA2 acancer gene

    Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variations in the BRCA2 breast and ovarian cancer gene with clinical information from women who received genetic testing to determine the clinical importance of many BRCA2 variants of uncertain significance (VUS). The findings were published today in a study

    New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian disease

    Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced effective results, dramatically restricting tumor growth and diminishing tumor mass. Designed especially for ovarian cancers that are resistant to conventional therapies, the new radiopharmaceutical could be produced in 25 minutes at reduced cost, which contributes to better efficiency compared with alternative procedures. This